BCHE and major depressive disorder: However, a meta-analysis revealed that the use of cholinesterase inhibitors as adjunctive antidepressant therapy had no clear benefit in older adults with depression (McDermott and Gray, 2012), suggesting that blood cytokine reductions brought about by acetylcholine manipulations might not be sufficient to attenuate depressive symptoms in patients with major depressive disorder.